Your browser doesn't support javascript.
[Mahuang (herbaceous stem of Ephedra spp.): chemistry, pharmacodynamics, and pharmacokinetics].
Tian, Nan-Nan; Yang, Xi-He; Zhu, Ya-Xuan; Zeng, Xue-Shan; Yuan, Jia-Ye; Yang, Jun-Ling; Jia, Wei-Wei; Li, Chuan.
  • Tian NN; Graduate School, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
  • Yang XH; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
  • Zhu YX; Graduate School, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
  • Zeng XS; Graduate School, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
  • Yuan JY; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
  • Yang JL; Graduate School, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
  • Jia WW; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
  • Li C; Graduate School, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203, China.
Zhongguo Zhong Yao Za Zhi ; 47(13): 3409-3424, 2022 Jul.
Article in Chinese | MEDLINE | ID: covidwho-1939525
ABSTRACT
The Chinese medicinal herb Mahuang is herbaceous stem of Ephedra sinica, E. intermedia, or E. equisetina(Family, Ephedraceae). In China, Mahuang has been used, all the way over a millennium, as a key component herb of many herbal medicines for management of epidemics of acute respiratory illness and is also used in officially recommended herbal medicines for COVID-19. Mahuang is the first-line medicinal herb for cold and wheezing and also an effective diuretic herb for edema. However, Mahuang can also exert significant adverse effects. The key to safety and effectiveness is rational and precise use of the herb. In this review article, we comprehensively summarize chemical composition of Mahuang and associated differences in pharmacognosy, pharmacodynamics and pharmacokinetics of Mahuang compounds, along with the adverse effects of Mahuang compounds and products. Based on full understanding of how Mahuang is used in Chinese traditional medicine, systematic research on Mahuang in line with contemporary standards of pharmaceutical sciences will facilitate promoting Chinese herbal medicines to become more efficient in management of epidemic illnesses, such as COVID-19. To this end, we recommend research on Mahuang of two aspects, i.e., pharmacological investigation for its multicompound-involved therapeutic effects and toxicological investigation for clinical manifestation of the adverse effects, chemicals responsible for the adverse effects, and conditions for safe use of the herb and the herb-containing medicines.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drugs, Chinese Herbal / Ephedra / Ephedra sinica / COVID-19 Drug Treatment Type of study: Prognostic study / Systematic review/Meta Analysis Topics: Traditional medicine Limits: Humans Language: Chinese Journal: Zhongguo Zhong Yao Za Zhi Journal subject: Pharmacology / Complementary Therapies Year: 2022 Document Type: Article Affiliation country: J.cnki.cjcmm.20220425.601

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Drugs, Chinese Herbal / Ephedra / Ephedra sinica / COVID-19 Drug Treatment Type of study: Prognostic study / Systematic review/Meta Analysis Topics: Traditional medicine Limits: Humans Language: Chinese Journal: Zhongguo Zhong Yao Za Zhi Journal subject: Pharmacology / Complementary Therapies Year: 2022 Document Type: Article Affiliation country: J.cnki.cjcmm.20220425.601